The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2015
Filed:
Sep. 29, 2014
Applicant:
Oncotherapy Science, Inc., Kanagawa, JP;
Inventors:
Yasuharu Nishimura, Kumamoto, JP;
Katsunori Imai, Kumamoto, JP;
Yusuke Nakamura, Tokyo, JP;
Takuya Tsunoda, Kanagawa, JP;
Assignee:
OncoTherapy Science, Inc., Kanagawa, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 1/00 (2006.01); A01K 61/00 (2006.01); A01K 67/00 (2006.01); A01K 67/027 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); C12N 9/14 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00 (2013.01); A01K 67/0278 (2013.01); A61K 38/16 (2013.01); A61K 39/0011 (2013.01); C07K 14/47 (2013.01); C07K 14/4748 (2013.01); C12N 9/14 (2013.01); C12Y 306/04004 (2013.01); A01K 2207/15 (2013.01); A01K 2217/052 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A01K 2267/0387 (2013.01); A61K 2039/5152 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/55 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); C12N 2799/027 (2013.01);
Abstract
The present invention provides oligopeptides comprising the amino acid sequence selected from the group consisting of SEQ ID NOs: 3, 4 and 5. The present invention also provides a pharmaceutical composition containing the amino acid sequence of selected from the group consisting of SEQ ID NOs: 3, 4 and 5 formulated for the treatment or prevention of cancer in a subject. Furthermore, the present invention provides a method of inducing immune response using such oligopeptides and pharmaceutical agents.